Aberration of FHIT Gene is Associated with Increased Tumor Proliferation and Decreased Apoptosis - Clinical Evidence in Lung and Head and Neck Carcinomas

Molecular Medicine

Volumn 7, Issue 7, 2001, Pages 442-453

  Pavelić, Krešimir ^a   Križanac, Šimun ^a   Čačev, Tamara ^a   Hadžija, Marijana Popovič ^a   Radošević, Senka ^b   Crnić, Ivana ^a   Levanat, Sonja ^a   Kapitanović, Sanja ^a  

^a RUDER BO KOVI INSTITUTE   (Croatia)

^b PLIVA CROATIA LTD   (Croatia)

Author keywords

[No Author keywords available]

Indexed keywords

ACID ANHYDRIDE HYDROLASE; CDKN1A PROTEIN, HUMAN; CYCLIN DEPENDENT KINASE INHIBITOR 1A; CYCLINE; DNA; FRAGILE HISTIDINE TRIAD PROTEIN; TUMOR PROTEIN;

ADULT; AGED; APOPTOSIS; ARTICLE; CELL DIVISION; CHROMOSOME FRAGILITY; FEMALE; GENE EXPRESSION; GENETICS; HEAD AND NECK TUMOR; HETEROZYGOSITY LOSS; HUMAN; IMMUNOHISTOCHEMISTRY; LUNG TUMOR; MALE; METABOLISM; MIDDLE AGED; MUTATION; PATHOLOGY; PROGNOSIS; SQUAMOUS CELL CARCINOMA; TUMOR SUPPRESSOR GENE;

ACID ANHYDRIDE HYDROLASES; ADULT; AGED; APOPTOSIS; CARCINOMA, SQUAMOUS CELL; CELL DIVISION; CHROMOSOME FRAGILITY; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; DNA, NEOPLASM; FEMALE; GENE EXPRESSION; GENES, TUMOR SUPPRESSOR; HEAD AND NECK NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; LOSS OF HETEROZYGOSITY; LUNG NEOPLASMS; MALE; MIDDLE AGED; MUTATION; NEOPLASM PROTEINS; PROGNOSIS;

EID: 0035409072     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03401849     Document Type: Article

References (35)

1. Sozzi G, Veronese ML, Negrini M, et al. (1996) The FHIT gene at 3p14.2 is abnormal in lung cancer. Cell 85: 17-26.
2. Kastury K, Baffa R, Druck T, et al. (1996) Potential gastrointestinal tumor suppressor locus at the 3p14.2 FRA3B site identified by homozygous deletions in tumor cell lines. Cancer Res. 56: 978-983.
3. Ohta M, Inoue H, Cotticelli MG, et al. (1996) The human FHIT gene, spanning the chromosome 3p14.2 fragile site acid renal carcinoma-associated T(3-8) breakpoint, is abnormal in digestive tract cancers. Cell 84: 587-597.
4. Virgilio L, Shuster M, Gollin SM, et al. (1996) FHIT gene alterations in head and neck squamous cell carcinomas. Proc. Natl. Acad. Sci. U.S.A. 93: 9770-9775.
5. Lubinski J, Hadaczek P, Podolski J, et al. (1994) Common regions of deletion in chromosome regions 3p12 and 3p14.2 in primary clear cell renal carcinomas. Cancer Res. 54: 3710-3713.
6. Tokuchi Y, Kobayashi Y, Hayashi S, et al. (1999) Abnormal FHIT transcripts found in both lung cancer and normal lung tissue. Genes Chromosomes Cancer Z4: 105-111.
7. 3-triphosphate hydrolase. Biochemistry 35: 11529-11535.
8. Wang N, Perkins KL. (1984) Involvement of band 3p14 in t(3;8) hereditary renal carcinoma. Cancer Genet. Cytogenet. 11: 479-481.
9. Croce CM, Sozzi G, Huebner K. (1999) Role of FHIT in human cancer. J. Clin. Oncol. 17: 1618-1624.
10. Ahsee KW, Cooke TG, Pickford IR, Soutar D, Balmain A. (1994) An allelotype of squamous carcinoma of the head and neck using microsatellite markers. Cancer Res. 54: 1617-1621.
11. Ishwad CS, Ferrell RI, Rossie KM, et al. (1996) Loss of heterozygosity of the short arm of chromosomes 3 and 9 in oral cancer. Int. J. Cancer 69: 1-4.
12. Mao L, Lee JS, Fan YH, et al. (1996) Frequent microsatellite alterations of chromosomes 9p21 and 3p14 in oral premalignant lesions and their value in cancer risk assessment. Nat Med 2: 682-685.
13. Wu CL, Sloan P, Read AP, Harris R, Thakker N. (1994) Deletion mapping on the short arm of chromosome 3 in squamous cell carcinoma of the oral cavity. Cancer Res. 54: 6484-6488.
14. Sozzi G, Sard L, De Gregorio L, et al. (1997) Association between cigarette smoking and FHIT gene alterations in lung cancer. Cancer Res. 57: 2121-2123.
15. Siprashvili Z, Sozzi G, Barnes LD, et al. (1997) Replacement of FHIT in cancer cells suppresses tumorigenecity. Proc. Natl Acad. Sci. U.S.A. 94: 13771-13776.
16. Sard L, Accornero P, Tornielli S, et al. (1996) The tumorsuppressor gene FHIT is involved in the regulation of apoptosis and in cell cycle control. Proc. Natl. Acad. Sci. U.S.A. 96: 8489-8492.
17. Ji L, Fang BL, Yen N, Fong K, Minna JD, Roth JA. (1999) Induction of apoptosis and inhibition of tumorigenicity and tumor growth by adenovirus vector-mediated fragile histidine triad (FHIT) gene overexpression. Cancer Res. 59: 3333-3339.
18. Fong LYY, Fidanza V, Zanesi N, et al. (2000) Muir-Torre-like syndrome in FHIT-deficient mice. Proc. Natl. Acad. Sci. U.S.A. 97: 4742-4747.
19. Spaventi R, Pečur L, Pavelić K, Pavelić ZP, Spaventi Š, Stambrook PJ. (1994) Human tumor bank in Croatia: a possible model for a small bank as a part of the future European tumor bank network. Eur J. Cancer 30A: 419-419.
20. Pavelić K, Pavelić ZP, Denton D, Reising J, Khalily M, Preisler HD. (1990) Immunohistochemical detection of C-MYC oncoprotein in paraffin embedded tissue. J Exp. Pathol 5: 143-153.
21. Baffa R, Veronese ML, Santoro R, et al. (1998) Loss of FHIT expression in gastric carcinoma. Cancer Res. 58: 4708-4714.
22. Druck T, Hadaczek P, Fu TB, et al. (1997) Structure and expression of the human FHIT gene in normal and tumor cells. Cancer Res. 57: 504-512.
23. Gall-Trošelj K, Kušić B, Pećina-Šlaus N, Pavelić K, Pavelić J. (1995) Nested polymerase chain reaction for detection of hepatitis C virus RNA in blood derivatives. Eur. J. Clin. Chem. Clin. Biochem. 33: 733-736.
24. Pavelić K, Kapitanović S, Radošević S, et al. (2000) Increased activity of nm23-H1 gene in squamous cell carcinoma of the head and neck is associated with advanced disease and poor prognosis. J. Mol. Med. 78: 111-118.
25. Herrmann M, Lorenz HM, Voll R, Grunke M, Woith W, Kalden JR. (1994) A rapid and simple method for the isolation of apoptotic DNA fragments. Nucleic Acids Res. 22: 5506-5507.
26. Fong KM, Biesterveld EJ, Virmani A, et al. (1997) FHIT and FRA3B 3p14.2 allele loss are common in lung cancer and preneoplastic bronchial lesions and are associated with cancerrelated FHIT cDNA splicing aberrations. Cancer Res. 57: 2256-2267.
27. Lux A, Bardenhener W, Michael D, et al. (1997) Identification of novel expressed sequence tags within the FHIT gene locus in human chromosome region 3p14.2. Hum. Genet. 100: 90-95.
28. Eldeiry WS, Tokino T, Velculescu VE, et al. (1993) WAF1, a potential mediator of p53 tumor suppression. Cell 75: 817-825.
29. Harper JW, Adami GR, Wei N, Keyomarski K, Elledge SJ. (1993) The p21 CDK-interacting protein CIP1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75: 805-816.
30. Xiong Y, Hannon GJ, Zhang H, Casso D, Kobayashi R, Beach D. (1993) p21 is a universal inhibitor of cyclin kinases. Nature 366: 701-704.
31. Pace HC, Carrison PN, Robinson AK, et al. (1998) Genetic, biochemical, and crystallographic characterization of FHIT-substrate complexes as the active signaling form of FHIT. Proc. Natl. Acad. Sci. U.S.A. 95: 5484-5489.
32. Kisselev LL, Justesen J, Wolfson AD, Frolova LY. (1998) Diadenosine oligophosphates (AP(N)A), a novel class of signaling molecules. FEBS Lett. 427: 157-163.
33. Tanimoto K, Hayashi S, Tsuchiya E, et al. (2000) Abnormalities of the FHIT gene in human oral carcinogenesis. Br. J. Cancer 82: 838-843.
34. Wistuba II, Behrens C, Virmani AK, et al. (2000) High resolution chromosome 3p allelotyping of human lung cancer and preneoplastic/preinvasive bronchial epithelium reveals multiple, discontinuous sites of 3p allele loss and three regions of frequent breakpoints. Cancer Res. 60: 1949-1960.
35. Denissenko MF, Pao A, Tang M, Pfeifer GP. (1996) Preferential formation of benzo[α]pyrene adducts at lung cancer mutational hotspots in p53. Science 274: 430-432.